Yes a complete overreaction.
We got smashed early in the week with the fears of a US recession, then further smashed after the trial results along with our great Angleman results.
it is hard to watch but to be frank I’m in until a buyout so I am just biding time until that occurs.
My main fear is that market makers are pushing this down to reduce any buyout figure, but I trust Jon knows what we have and what it’s worth, hence the speak of taking 2 indications through to ph3 if BP don’t offer fair value for our “platform” drug.
Just have to work longer than I wanted. Such is life…,
That may be considered a selfish view as I do want this drug to be in the hands of those that need it ASAP, but I’ve been here a long time and would like closure on this.
NEU has been completely de-risked at this point...., page-13
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.15 |
Change
-0.940(5.50%) |
Mkt cap ! $2.064B | |||
| Open | High | Low | Value | Volume |
| $15.04 | $16.33 | $14.65 | $25.91M | 1.638M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 125 | $16.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.20 | 1500 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |